November 8, 2019

Around the nation: How Sanford wants to tackle nurse retention

Daily Briefing

    The initiative includes a nurse residency that will cover topics such as critical thinking, critical reasoning, patient safety, interpersonal communication, evidence-based practice, and patient- and family-centered care, in today's bite-sized hospital and health industry news from Pennsylvania, South Dakota, and Utah.

    • Pennsylvania: Geisinger Commonwealth School of Medicine on Wednesday announced that it will allow students who agree to practice primary care after residency at Geisinger Health to attend school tuition-free. The health system hopes the program will help address its primary care physician shortage. Geisinger projects it will be short 309 family medicine doctors by 2022, in line with a projected nationwide shortage (Castellucci, Modern Healthcare, 11/6).

    • South Dakota: Sanford Health has launched a year-long retention program aimed at supporting new nurses in their jobs and helping jumpstart long-term careers with the health system. The initiative will create a residency program for new nurses that lasts beyond their four to six months of initial training, a time in which new nurses can hit a lull and become frustrated with their jobs. The residency curriculum covers topics such as critical thinking, critical reasoning, patient safety, interpersonal communication, evidence-based practice, and patient- and family-centered care (Fugleberg, Inforum, 11/5).

    • Utah: Intermountain Healthcare President and CEO Marc Harrison announced this week that he will be undergoing treatment for multiple myeloma. Harrison will remain CEO while undergoing treatment and is expected to return to the health system in early 2020 (Commins, HealthLeaders Media, 11/5).

    Have a Question?

    x

    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.

    X
    Cookies help us improve your website experience. By using our website, you agree to our use of cookies.